2023 Policy Forecasts
Welcome to Capstone’s annual forecast of unappreciated policy and regulatory themes companies, investors, and, industries should expect to play out over the course of the year.
Connect with us
Our Latest Insights
What Regulators Are Doing About Insurer Investment in Private Assets
Capstone believes the National Association of Insurance Commissioners (NAIC) is approaching life insurer investment in complex assets through targeted moves related to disclosure and transparency, as well as tactical changes to capital charges, and is not looking to...
The Emerging Packaging Laws Boxing in Producers on Costs
Momentum for legislation governing extended producer responsibility (EPR) for plastics and packaging has been gathering steam in states with solid Democratic governing majorities. The key reason why these packaging EPR laws are popular in those states is that...
FDA Cracks Down on GLP-1 Compounding While Bolstering Peptides and Hormone Therapies
Capstone believes that while continued scrutiny by the Food and Drug Administration (FDA) has ended large-scale GLP-1 compounding, non-GLP-1 product categories are unlikely to face targeted enforcement. Products such as peptides and hormone therapies are also likely...































